A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis
Clinical trial NCT01837420 · COMPLETED
Trial details
- NCT number
- NCT01837420
- Sponsor
- Vascular Biogenics Ltd. operating as VBL Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2014-11-01
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.